Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Free radicals, antioxidant defense systems, and schizophrenia
HTML
Details
Locations
Year:
2013
Type:
review
Source:
Progress in Neuro-Psychopharmacology and Biological Psychiatry
DOI:
10.1016/j.pnpbp.2013.02.015
Authors:
Jing Qin Wu,
Thomas R. Kosten,
Xiang Yang Zhang
Institutions:
Peking University,
Beijing HuiLongGuan Hospital,
Schizophrenia Research Institute,
University of Newcastle Australia,
Michael E. DeBakey VA Medical Center,
Baylor College of Medicine
show all 6
Language:
English
Topic:
Schizophrenia research and treatment
Subfield:
Psychiatry and Mental health
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funders:
Stanley Medical Research Institute,
National Health and Medical Research Council,
National Institute of Mental Health,
National Institute on Drug Abuse
Awards:
SMRI Treatment Trial 03T-459: Celecoxib for Schizophrenia,
SMRI Treatment Trial 05T-726: Artemisinin for Schizophrenia,
Tropisetron with Risperidone for Schizophrenia,
Comorbidity in Cocaine and Opioid Pharmacotherapy,
G7382832268
OpenAlex ID:
W2094905804
FWCI:
2.488
Cites:
100
Cited by:
431
Related to:
10